Panofoli Capsule: Your High-Demand PCD Pharma Franchise in Gastroenterology

About Pancrelipase + Amylase + Protease: Essential for Digestive Health

Tapping into the Growing Market for Digestive Enzyme Supplements

Why Panofoli Capsule is a High-Profit Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Home/Products /pancrelipase-500-usp-amylase-30000-usp-protease-30000-usp-capsule

About the Product

Description


Panofoli Capsule is an essential medication for treating Exocrine Pancreatic Insufficiency (EPI), a condition where the pancreas fails to produce sufficient digestive enzymes. Our formulation combines a powerful blend of Pancrelipase, Amylase, and Protease to restore the body's natural digestive capabilities. These enzymes work synergistically to break down fats, carbohydrates, and proteins, ensuring proper nutrient absorption and alleviating uncomfortable symptoms such as bloating, abdominal pain, gas, and fatty stools. This product is a crucial lifeline for patients with chronic pancreatitis, cystic fibrosis, or other conditions affecting pancreatic function, providing them with a better quality of life and preventing severe complications like malnutrition.

The market for digestive enzyme supplements is a fast-growing and vital segment within the Indian pharmaceutical industry. Driven by an increasing prevalence of gastrointestinal disorders, changing dietary habits, and a rising awareness of digestive health, the demand for a reliable product like Panofoli Capsule is consistently high. The chronic nature of EPI ensures a stable, long-term prescription base, making this a highly attractive and profitable opportunity for B2B pharma distributors. Entering this specialized market with a quality product gives you a significant competitive advantage and a clear path to sustainable business growth.

We are dedicated to empowering our franchise partners with all the tools necessary for success in this professional market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals and patients. We provide a complete promotional and marketing kit, including detailed product literature, visual aids, and samples, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality and essential medicine.

Common side effects may include abdominal discomfort, nausea, diarrhea, or constipation. Rare but serious side effects include allergic reactions or severe abdominal pain.

Indicated for the treatment of pancreatic insufficiency, chronic pancreatitis, cystic fibrosis, or as an adjunct therapy in individuals with pancreatic dysfunction to aid in digestion and nutrient absorption.

Use under medical supervision. Patients with a history of gout, high uric acid levels, or allergic reactions to pancreatic enzymes should inform their healthcare provider before use.

Store at room temperature in a cool, dry place. Keep the capsule tightly closed and away from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pancrelipase 500 USP (Amylase 30,000 USP + Protease 30,000 USP) Capsule in the PCD pharma franchise market?

Pancrelipase 500 USP (Amylase 30,000 USP + Protease 30,000 USP) Capsule has strong demand in the gastroenterology, digestive enzyme replacement, and nutritional support segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal and specialty healthcare portfolios.

Why should medical distributors include Pancrelipase 500 USP (Amylase 30,000 USP + Protease 30,000 USP) Capsule in their product range?

Medical distributors and agencies can benefit from consistent demand for pancreatic enzyme replacement therapy under medical supervision. Pancrelipase contains digestive enzymes including Amylase, Protease, and Lipase that help digest carbohydrates, proteins, and fats This formulation provides Amylase 30,000 USP and Protease 30,000 USP along with lipase activity as per the product specification, supporting comprehensive digestion Commonly prescribed for the management of exocrine pancreatic insufficiency associated with conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or pancreatic disorders, as advised by healthcare professionals Helps improve digestion, nutrient absorption, and supports the management of symptoms such as steatorrhea, bloating, and malabsorption caused by pancreatic enzyme deficiency Capsule formulation provides convenient administration and is generally taken with meals or snacks as directed by the physician Requires individualized dosing based on the patient's condition, dietary intake, and treatment response Frequently utilized in gastroenterology clinics, hospitals, nutrition support centers, and general medicine practices Widely prescribed by gastroenterologists and general physicians This strengthens a comprehensive gastroenterology and digestive healthcare portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pancrelipase 500 USP (Amylase 30,000 USP + Protease 30,000 USP) Capsule with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, long-term patient usage, reliable supply chain support, specialty gastroenterology market opportunities, and attractive margins in the digestive enzyme replacement segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.